
Sipai Health Technology Co., Ltd.
0314.HKHKSEHealthcareMedical - Distribution
最新資料
HK$1.61
+HK$0.08 · +5.23%
0314.HK公司概覽
盤中時間採用HKT。市場資料可能有所延遲。
公司概況
公司網站Sipai Health Technology Co., Ltd. is a Chinese enterprise specializing in medical technology and health management. Its business operations are diversified across three primary divisions: Specialty Pharmacy, Physician Research Assistance, and Health Insurance Services. The Specialty Pharmacy division manages a network of dedicated pharmacies and is also involved in the distribution of pharmaceutical products to drug manufacturers and other supply chain partners. Through its Physician Research Assistance segment, Sipai Health provides comprehensive site management organization (SMO) support to pharmaceutical firms and clinical research institutions. These services encompass a broad spectrum, including site identification and setup, patient acquisition and oversight, data and document handling, on-site logistical management of drugs and biosamples, and trial conclusion. Additionally, this segment offers specialized image management for clinical studies. The Health Insurance Services division functions as an intermediary, delivering brokerage solutions to various insurance providers. Established in 2014, the company's headquarters are situated in Guangzhou, China.
- 產業
- Medical - Distribution
- 部門
- Healthcare
- 總部
- CN
- 執行長
- Xuguang Ma
- 上市以來
- 2022年12月23日
- 僱員
- 3,131
市場位置
日內區間
目前HK$1.61,
52週區間
目前HK$1.61,
- 開盤價
- HK$1.53
- 前收盤價
- HK$1.53
- 成交量
- 78.98萬
- 0.79× 平均值
- 平均成交量
- 100.37萬
- 日均成交量
- 市值
- 11.71億 HKD
- 貝塔
- -0.58
- 市場參考 1
- 50天平均值
- HK$1.3606
- 高於平均水平+18.33%
- 200天平均值
- HK$1.9509
- 低於平均水平-17.47%
財務數據
財務快照
最近十二個月估值與收益率
- 企業價值
- 10.63億 CNY
- 本益比(TTM)
- -11.76×
- 股價淨值比(TTM)
- 0.9×
- 股價營收比(TTM)
- 0.82×
- EV/EBITDA
- -14.07×
- 盈餘收益率
- -8.99%
- 自由現金流收益率
- 0.01%
- 股息率
- 0.00%
獲利能力和效率
- 毛利率
- 14.39%
- 營業利益率
- -5.15%
- 淨利潤率
- -5.88%
- 股東權益報酬率
- -12.92%
- 資產報酬率
- -7.55%
- 投入資本報酬率
- -10.78%
財務健康
- 負債權益比
- 0.02×
- 流動比率
- 1.83×
財報歷史與展望
- 最新每股收益結果
- 0.08
EPS:實際值與預估值
近期已公布業績
營收:實際值與預估值
近期已公布業績
0314.HK同業公司
持有0314.HK的ETF
報告持有此股票曝險的交易所交易基金。
Dimensional - Emerging Markets Core Equity 2 ETFDFEM6.21萬0.00%94.91億 USD0.39%US$39.93—
State Street SPDR S&P Emerging Markets Small Cap ETFEWX4.99萬0.01%6.86億 USD0.65%US$72.22—
Dimensional World ex U.S. Core Equity 2 ETFDFAX1.89萬0.00%125.66億 USD0.28%US$38.16—
State Street SPDR S&P China ETFGXC18320.00%4.75億 USD0.59%US$91.50—
Dimensional - Emerging Markets Core Equity 2 ETFDFEM- 市場價值
- 6.21萬
- 重量
- 0.00%
- AUM
- 94.91億 USD
- 費用率
- 0.39%
- 價格 / 1日
- US$39.93—
State Street SPDR S&P Emerging Markets Small Cap ETFEWX- 市場價值
- 4.99萬
- 重量
- 0.01%
- AUM
- 6.86億 USD
- 費用率
- 0.65%
- 價格 / 1日
- US$72.22—
Dimensional World ex U.S. Core Equity 2 ETFDFAX- 市場價值
- 1.89萬
- 重量
- 0.00%
- AUM
- 125.66億 USD
- 費用率
- 0.28%
- 價格 / 1日
- US$38.16—
State Street SPDR S&P China ETFGXC- 市場價值
- 1832
- 重量
- 0.00%
- AUM
- 4.75億 USD
- 費用率
- 0.59%
- 價格 / 1日
- US$91.50—
繼續GoAI的研究
在 GoAI 中研究0314.HKresearch.disclaimer





